Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57099 | 0.84 | GRM4 (0.44) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL29549932 | 0.84 | GRM4 (0.44) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL1638844 | 0.84 | ALDH1A1 (0.43) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL143632 | 0.83 | KDM4E (0.46) | KMT2AMAPTUSP2ALDH1A1KDM4E | |
| SCHEMBL31389161 | 0.83 | KMT2A (0.38) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL11411081 | 0.83 | KMT2A (0.38) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL6959141 | 0.82 | GRM4 (0.43) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL14248985 | 0.81 | KMT2A (0.63) | KMT2AMAPTUSP2MEN1POLB | |
| SCHEMBL1638841 | 0.81 | FABP4 (0.46) | KMT2AMAPTRAB9ANPC1USP2 | |
| SCHEMBL833161 | 0.80 | GRM4 (0.44) | KMT2AMAPTRAB9ANPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572728-B1 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2014-06-25 | — | — | EP | claimed |
| CN-101503351-B | Brominated rare-earth carboxylate, as well as preparation and use thereof | HUAIHAI INST TECHNOLOGY | 2012-08-15 | — | — | CN | claimed |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-05-10 | — | — | US | claimed |
| US-8129330-B2 | Complex of polyoxyethylene glycol with active material | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-03-06 | — | — | US | claimed |
| CN-101503351-A | Brominated rare-earth carboxylate, as well as preparation and use thereof | HUAIHAI INST TECHNOLOGY (CN) | 2009-08-12 | — | — | CN | claimed |
| JP-2006510601-A | — | — | 2006-03-30 | — | — | JP | claimed |
| EP-1572728-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | Mountain View Pharmaceuticals, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1421175-A4 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1421175-A2 | POLYMER STABILIZED PROTEINASES | Mountain View Pharmaceuticals, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| WO-2004030617-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2004-04-15 | — | — | WO | claimed |
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20030012777-A1 | Polymer conjugates of proteinases | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2003-01-16 | — | — | US | claimed |
| WO-2003002716-A2 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| CN-122095024-A | Flame-retardant aromatic polycarbonate resin composition and molded article thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4406536-A2 | CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA | The Regents of The University of Colorado, A Body Corporate (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-3712264-B1 | CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA | UNIV COLORADO REGENTS (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-0402674-A2 | Process for preparing Polycarbonate-silicon block copolymer compositions | GENERAL ELECTRIC COMPANY (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0382800-A1 | IMPACT MODIFIED POLYAMIDE/AROMATIC POLYCARBONATE BLENDS | GENERAL ELECTRIC COMPANY (US) | 1990-08-22 | — | — | EP | disclosed |
| WO-1990002156-A1 | IMPACT MODIFIED POLYAMIDE/AROMATIC POLYCARBONATE BLENDS | GENERAL ELECTRIC COMPANY (US) | 1990-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | KMT2A 2567/4885MAPT 1859/4885RAB9A 3103/4885 |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | KMT2A 2567/4885MAPT 1859/4885RAB9A 3103/4885 |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | CD14, HLA-C, HLA-A | KMT2A 2567/4885MAPT 1859/4885RAB9A 3103/4885 |
| US-20030012777-A1 | Polymer conjugates of proteinases | PRNP, PRSS3, PRSS1 | KMT2A 2115/4885MAPT 93/4885RAB9A 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.